Calcium phosphate surface tailoring technologies for drug delivering and tissue engineering

Surface Tailoring of Inorganic Materials for Biomedical Applications

Volumn , Issue , 2012, Pages 43-111

  Drouet, Christophe ^a   Gomez Morales, Jaime ^b   Iafisco, Michele ^c,d   Sarda, Stephanie ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b LABORATORIO DE ESTUDIOS CRISTALOGRÁFICOS   (Spain)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Biomineralization; Bone tissue engineering; Calcium phosphates; Drug delivery; Nanocrystalline apatites

Indexed keywords

EID: 84882602730     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805462611201010043     Document Type: Chapter

References (247)

1. Dorozhkin SV. Bioceramics of calcium orthophosphates. Biomaterials 2010 Mar; 31(7): 1465-85.
2. Dorozhkin SV. Nanosized and nanocrystalline calcium orthophosphates. Acta Biomater 2010 Mar; 6(3): 715-34.
3. Dorozhkin SV. Calcium orthophosphates. J Mater Sci 2007; 42(4): 1061-95.
4. Loveridge N. Bone: More than a stick. J Anim Sci 1999; 77 Suppl 2: 190-6.
5. Reddi AH. Symbiosis of Biotechnology and Biomaterials -Applications in Tissue Engineering of Bone and Cartilage. J Cell Biochem 1994; 56(2): 192-5.
6. Cowles EA, DeRome ME, Pastizzo G, Brailey LL, Gronowicz GA. Mineralization and the expression of matrix proteins during in vivo bone development. Calcified Tissue Int 1998; 62(1): 74-82.
7. Tzaphlidou M. Bone Architecture: Collagen Structure and Calcium/Phosphorus Maps. J Biol Phys 2008; 34(1-2): 39-49.
8. Urist MR. Bone: Formation by autoinduction (Reprinted from Science, vol 150, pg 893-899, 1965). Clin Orthop Relat R 2002; (395): 5-10.
9. Wozney JM. The Bone Morphogenetic Protein Family and Osteogenesis. Mol Reprod Dev 1992; 32(2): 160-7.
10. Manolagas SC. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. J Aging Phys Activ 2000; 8(3): 248-.
11. Legeros RZ, Craig RG. Strategies to Affect Bone Remodeling -Osteointegration. J Bone Miner Res 1993; 8 Suppl 2: S583-S96.
12. Boskey AL. Mineralization of bones and teeth. Elements 2007; 3(6): 385-91.
13. Palmer LC, Newcomb CJ, Kaltz SR, Spoerke ED, Stupp SI. Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel. Chem Rev 2008; 108(11): 4754-83.
14. Weiner S, Wagner HD. The material bone: Structure mechanical function relations. Annu Rev Mater Sci 1998; 28: 271-98.
15. Fernandez-Moran H, Engstrom A. Electron microscopy and x-ray diffraction of bone. Biochim Biophys Acta 1957; 23(2): 260-4.
16. Traub W, Arad T, Weiner S. Three-dimensional ordered distribution of crystals in turkey tendon collagen fibers. Proc Natl Acad Sci U S A. 1989; 86(24): 9822-6.
17. Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006; 38(11): 1310-5.
18. Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, Martin GR. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981; 26(1 Pt 1): 99-105.
19. Cui FZ, Li Y, Ge J. Self-assembly of mineralized collagen composites. Mat Sci Eng R 2007; 57(1-6): 1-27.
20. Olszta MJ, Cheng XG, Jee SS, Kumar R, Kim YY, Kaufman MJ, et al. Bone structure and formation: A new perspective. Mat Sci Eng R 2007; 58(3-5): 77-116.
21. Burger C, Zhou HW, Wang H, Sics I, Hsiao BS, Chu B, et al. Lateral packing of mineral crystals in bone collagen fibrils. Biophys J 2008; 95(4): 1985-92.
22. Wahl DA, Czernuszka JT. Collagen-hydroxyapatite composites for hard tissue repair. Eur Cells Mater 2006; 11: 43-56.
23. Fratzl P, Gupta HS, Paschalis EP, Roschger P. Structure and mechanical quality of the collagen-mineral nano-composite in bone. J Mater Chem 2004; 14(14): 2115-23.
24. Whittaker DK. Structural variations in the surface zone of human tooth enamel observed by scanning electron microscopy. Arch Oral Biol 1982; 27(5): 383-92.
25. Tamerler C, Sarikaya M. Molecular biomimetics: Genetic synthesis, assembly, and formation of materials using peptides. Mrs Bull 2008; 33(5): 504-10.
26. Arsenault AL, Robinson BW. The Dentino-Enamel Junction -a Structural and Microanalytical Study of Early Mineralization. Calcified Tissue Int 1989; 45(2): 111-21.
27. White SN, Luo W, Paine ML, Fong H, Sarikaya M, Snead ML. Biological organization of hydroxyapatite crystallites into a fibrous continuum toughens and controls anisotropy in human enamel. J Dent Res 2001; 80(1): 321-6.
28. Imbeni V, Kruzic JJ, Marshall GW, Marshall SJ, Ritchie RO. The dentin-enamel junction and the fracture of human teeth. Nat Mater 2005; 4(3): 229-32.
29. Paine ML, White SN, Luo W, Fong H, Sarikaya M, Snead ML. Regulated gene expression dictates enamel structure and tooth function. Matrix Biol 2001; 20(5-6): 273-92.
30. Wen HB, Moradian-Oldak J, Fincham AG. Dose-dependent modulation of octacalcium phosphate crystal habit by amelogenins. J Dent Res 2000; 79(11): 1902-6.
31. Cui FZ, Ge J. New observations of the hierarchical structure of human enamel, from nanoscale to microscale. J Tissue Eng Regen M 2007; 1(3): 185-91.
32. Wang RZ, Weiner S. Strain-structure relations in human teeth using Moire fringes. J Biomech 1998; 31(2): 135-41.
33. Kodaka T, Nakajima F, Higashi S. Structure of the So-Called Prismless Enamel in Human Deciduous Teeth. Caries Res 1989; 23(5): 290-6.
34. Daculsi G, Bouler JM, LeGeros RZ. Adaptive crystal formation in normal and pathological calcifications in synthetic calcium phosphate and related biomaterials. Int Rev Cytol 1997; 172: 129-91.
35. Kazama JJ, Amizuka N, Fukagawa M. Ectopic calcification as abnormal biomineralization. Ther Apher Dial 2006; 10: S34-S8.
36. Brancaccio D, Cozzolino M. The mechanism of calcium deposition in soft tissues. Contrib Nephrol 2005; 149: 279-86.
37. Achilles W, Jockel U, Schaper A, Burk M, Riedmiller H. In vitro Formation of Urinary Stones -Generation of Spherulites of Calcium-Phosphate in Gel and Overgrowth with Calcium-Oxalate Using a New Flow Model of Crystallization. Scanning Microscopy 1995; 9(2): 577-86.
38. Hayashizaki J, Ban S, Nakagaki H, Okumura A, Yoshii S, Robinson C. Site specific mineral composition and microstructure of human supra-gingival dental calculus. Arch Oral Biol 2008; 53(2): 168-74.
39. Marra SP, Daghlian CP, Fillinger MF, Kennedy FE. Elemental composition, morphology and mechanical properties of calcified deposits obtained from abdominal aortic aneurysms. Acta Biomater 2006; 2(5): 515-20.
40. Weissen-Plenz G, Nitschke Y, Rutsch F. Mechanisms of Arterial Calcification: Spotlight on the Inhibitors. Adv Clin Chem 2008; 46: 263-93.
41. Laird DF, Mucalo MR, Yokogawa Y. Growth of calcium hydroxyapatite (Ca-HAp) on cholesterol and cholestanol crystals from a simulated body fluid: A possible insight into the pathological calcifications associated with atherosclerosis. J Colloid Interf Sci 2006; 295(2): 348-63.
42. Wesson JA, Ward MD. Pathological biomineralization of kidney stones. Elements 2007; 3(6): 415-21.
43. Legeros RZ, Orly I, Legeros JP, Gomez C, Kazimiroff J, Tarpley T, et al. Scanning Electron-Microscopy and Electron-Probe Microanalyses of the Crystalline Components of Human and Animal Dental Calculi. Scanning Microscopy 1988; 2(1): 345-56.
44. Kirsch T. Determinants of pathological mineralization. Curr Opin Rheumatol2006; 18(2): 174-80.
45. Roveri N, Battistella E, Bianchi CL, Foltran I, Foresti E, Iafisco M, et al. Surface Enamel Remineralization: Biomimetic Apatite Nanocrystals and Fluoride Ions Different Effects J Nanomater. 2009: -.
46. Dorozhkin SV. Calcium orthophosphate cements for biomedical application. J Mater Sci 2008; 43(9): 3028-57.
47. Jandt KD. Evolutions, revolutions and trends in biomaterials science -A perspective. Adv Eng Mater 2007; 9(12): 1035-50.
48. LeGeros RZ. Calcium Phosphate-Based Osteoinductive Materials. Chem Rev 2008; 108(11): 4742-53.
49. Rivera EM, Araiza M, Brostow W, Castano VM, Diaz-Estrada JR, Hernandez R, et al. Synthesis of hydroxyapatite from eggshells. Mater Lett 1999; 41(3): 128-34.
50. Balazsi C, Weber F, Kover Z, Horvath E, Nemeth C. Preparation of calcium-phosphate bioceramics from natural resources. J Eur Ceram Soc 2007; 27(2-3): 1601-6.
51. Murugan R, Ramakrishna S. Crystallographic study of hydroxyapatite bioceramics derived from various sources. Cryst Growth Des 2005; 5(1): 111-2.
52. Roveri N, Palazzo B, Iafisco M. The role of biomimetism in developing nanostructured inorganic matrices for drug delivery. Expert Opin Drug Del 2008; 5(8): 861-77.
53. Lecomte A, Gautier H, Bouler JM, Gouyette A, Pegon Y, Daculsi G, et al. Biphasic calcium phosphate: A comparative study of interconnected porosity in two ceramics. J Biomed Mater Res B 2008; 84B(1): 1-6.
54. Daculsi G, Uzel AP, Weiss P, Goyenvalle E, Aguado E. Developments in injectable multiphasic biomaterials. The performance of microporous biphasic calcium phosphate granules and hydrogels. J Mater Sci-Mater M 2010; 21(3): 855-61.
55. Daculsi G, Laboux O, Malard O, Weiss P. Current state of the art of biphasic calcium phosphate bioceramics. J Mater Sci-Mater M 2003; 14(3): 195-200.
56. Sánchez-Salcedo S, Arcos D, Vallet-Regí M. Upgrading calcium phosphate scaffolds for tissue engineering applications. Key Eng Mater 2008; 377: 19-42.
57. Sayer M, Stratilatov AD, Reid J, Calderin L, Stott MJ, Yin X, et al. Structure and composition of silicon-stabilized tricalcium phosphate. Biomaterials 2003; 24(3): 369-82.
58. da Silva RV, Bertran CA, Kawachi EY, Camilli JA. Repair of cranial bone defects with calcium phosphate ceramic implant or autogenous bone graft. J Craniofac Surg 2007; 18(2): 281-6.
59. Astala R, Calderin L, Yin X, Stott MJ. Ab initio simulation of Si-doped hydroxyapatite. Chem Mater 2006; 18(2): 413-22.
60. Khalil KA, Kim HY, Kim SW, Kim KW. Observation of toughness improvement of the hydroxyapatite bioceramics densified using high-frequency induction heat sintering. Int J Appl Ceram Tec 2007; 4(1): 30-7.
61. Kobayashi S, Kawai W, Wakayama S. The effect of pressure during sintering on the strength and the fracture toughness of hydroxyapatite ceramics. J Mater Sci-Mater M 2006; 17(11): 1089-93.
62. Narasaraju TSB, Phebe DE. Some physico-chemical aspects of hydroxylapatite. J Mater Sci 1996; 31(1): 1-21.
63. Suchanek W, Yoshimura M. Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants. J Mater Res 1998; 13(1): 94-117.
64. Ramesh S, Tan CY, Bhaduri SB, Teng WD, Sopyan I. Densification behaviour of nanocrystalline hydroxyapatite bioceramics. J Mater Process Technol 2008; 206(1-3): 221-30.
65. Linhart W, Briem D, Amling M, Rueger JM, Windolf J. Mechanical failure of porous hydroxyapatite ceramics 7.5 years after implantation in the proximal tibial. Unfallchirurg. 2004; 107(2): 154-7.
66. Dorozhkin SV. Calcium orthophosphate-based biocomposites and hybrid biomaterials. J Mater Sci 2009; 44(9): 2343-87.
67. Best SM, Porter AE, Thian ES, Huang J. Bioceramics: Past, present and for the future. J Eur Ceram Soc 2008; 28(7): 1319-27.
68. Mastrogiacomo M, Scaglione S, Martinetti R, Dolcini L, Beltrame F, Cancedda R, et al. Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics. Biomaterials 2006; 27(17): 3230-7.
69. Karageorgiou V, Kaplan D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005; 26(27): 5474-91.
70. Lu JX, Flautre B, Anselme K, Hardouin P, Gallur A, Descamps M, et al. Role of interconnections in porous bioceramics on bone recolonization in vitro and in vivo. J Mater Sci-Mater M 1999; 10(2): 111-20.
71. Tancret F, Bouler JM, Chamousset J, Minois LM. Modelling the mechanical properties of microporous and macroporous biphasic calcium phosphate bioceramics. J Eur Ceram Soc 2006; 26(16): 3647-56.
72. Walsh D, Tanaka J. Preparation of a bone-like apatite foam cement. J Mater Sci-Mater M 2001; 12(4): 339-43.
73. Chevalier E, Chulia D, Pouget C, Viana M. Fabrication of porous substrates: A review of processes using pore forming agents in the biomaterial field. J Pharm Sci-Us. 2008; 97(3): 1135-54.
74. Gonzalez-McQuire R, Green D, Walsh D, Hall S, Chane-Ching JY, Oreffo ROC, et al. Fabrication of hydroxyapatite sponges by dextran sulphate/amino acid templating. Biomaterials 2005; 26(33): 6652-6.
75. Liu DM. Fabrication of hydroxyapatite ceramic with controlled porosity. J Mater Sci-Mater M 1997; 8(4): 227-32.
76. Walsh D, Boanini E, Tanaka J, Mann S. Synthesis of tri-calcium phosphate sponges by interfacial deposition and thermal transformation of self-supporting calcium phosphate films. J Mater Chem 2005; 15(10): 1043-8.
77. Charriere E, Lemaitre J, Zysset P. Hydroxyapatite cement scaffolds with controlled macroporosity: fabrication protocol and mechanical properties. Biomaterials 2003; 24(5): 809-17.
78. Araiza MA, Gomez-Morales J, Clemente RR, Castano VM. Conversion of the echinoderm Mellita eduardobarrosoi calcite skeleton into porous hydroxyapatite by treatment with phosphated boiling solutions. J Mater Synth Proces 1999; 7(4): 211-9.
79. Sopyan I, Mel M, Ramesh S, Khalid KA. Porous hydroxyapatite for artificial bone applications. Sci Technol Adv Mat 2007; 8(1-2): 116-23.
80. Brown WE, Chow LC, inventors; Dental restorative cement pastes.1985.
81. LeGeros, RZ, Chohayeb, A, Shulman, A. Apatitic Calcium Phosphates: Possible. Dental Restorative Materials. J Dent Res 1982; 61: 343-7.
82. Gbureck U, Barralet JE, Spatz K, Grover LM, Thull R. Ionic modification of calcium phosphate cement viscosity. Part I: hypodermic injection and strength improvement of apatite cement. Biomaterials 2004; 25(11): 2187-95.
83. Tagaya M, Goto H, Iinuma M, Wakamatsu N, Tamura Y, Doi Y. Development of self-setting Te-CP/alpha-TCP cement for pulpotomy. Dent Mater J 2005; 24(4): 555-61.
84. Driessens FCM, Planell JA, Boltong MG, Khairoun I, Ginebra MP. Osteotransductive bone cements. P I Mech Eng H 1998; 212(H6): 427-35.
85. Driessens FCM, Boltong MG, Bermudez O, Planell JA. Formulation and Setting Times of Some Calcium Orthophosphate Cements -a Pilot-Study. J Mater Sci-Mater M 1993; 4(5): 503-8.
86. Xia ZD, Grover LM, Huang YZ, Adamopoulos LE, Gbureck U, Triffitt JT, et al. In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line. Biomaterials 2006; 27(26): 4557-65.
87. Kudrman J, Fousek J, Brezina V, Mikova R, Vesely J. Titanium alloys for implants in medicine. Kovove Mater 2007; 45(4): 199-208.
88. Niinomi M. Mechanical biocompatibilities of titanium alloys for biomedical applications. J Mech Behav Biomed Mater 2008; 1(1): 30-42.
89. Raikar GN, Gregory JC, Ong JL, Lucas LC, Lemons JE, Kawahara D, et al. Surface Characterization of Titanium Implants. J Vac Sci Technol A 1995; 13(5): 2633-7.
90. Manara S, Paolucci F, Palazzo B, Marcaccio M, Foresti E, Tosi G, et al. Electrochemicallyassisted deposition of biomimetic hydroxyapatite-collagen coatings on titanium plate. Inorg Chim Acta 2008; 361(6): 1634-45.
91. Wennerberg A, Albrektsson T. Structural influence from calcium phosphate coatings and its possible effect on enhanced bone integration. Acta Odontol Scand 2009; 67(6): 333-40.
92. Schouten C, Meijer GJ, van den Beucken JJ, Leeuwenburgh SC, de Jonge LT, Wolke JG, et al. In vivo bone response and mechanical evaluation of electrosprayed CaP nanoparticle coatings using the iliac crest of goats as an implantation model. Acta Biomater 2010; 6(6): 2227-36.
93. de Jonge LT, Leeuwenburgh SC, van den Beucken JJ, te Riet J, Daamen WF, Wolke JG, et al. The osteogenic effect of electrosprayed nanoscale collagen/calcium phosphate coatings on titanium. Biomaterials 2010; 31(9): 2461-9.
94. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006; 27(15): 2907-15.
95. Degroot K, Geesink R, Klein CPAT, Serekian P. Plasma Sprayed Coatings of Hydroxylapatite. J Biomed Mater Res1987; 21(12): 1375-81.
96. Paital SR, Dahotre NB. Calcium phosphate coatings for bio-implant applications: Materials, performance factors, and methodologies. Mat Sci Eng R 2009; 66(1-3): 1-70.
97. Gómez Morales J, Rodríguez Clemente R, Armas B, Combescure C, Berjoan R, Cubo J, et al. Controlled Nucleation and Growth of Thin Hydroxyapatite Layers on Titanium Implants by Using Induction Heating Technique. Langmuir 2004; 20(13): 5174-8.
98. MacDonald DE, Betts F, Stranick M, Doty S, Boskey AL. Physicochemical study of plasmasprayed hydroxyapatite-coated implants in humans. J Biomed Mater Res 2001; 54(4): 480-90.
99. Lusquinos F, De Carlos A, Pou J, Arias JL, Boutinguiza M, Leon B, et al. Calcium phosphate coatings obtained by Nd : YAG laser cladding: Physicochemical and biologic properties. J Biomed Mater Res A 2003; 64A(4): 630-7.
100. Yang YZ, Kim KH, Ong JL. Review on calcium phosphate coatings produced using a sputtering process -an alternative to plasma spraying. Biomaterials 2005; 26(3): 327-37.
101. Wei M, Ruys AJ, Swain MV, Kim SH, Milthorpe BK, Sorrell CC. Interfacial bond strength of electrophoretically deposited hydroxyapatite coatings on metals. J Mater Sci-Mater M 1999; 10(7): 401-9.
102. Wang DG, Chen CZ, Ting H, Lei TQ. Hydroxyapatite coating on Ti6Al4V alloy by a sol-gel method. J Mater Sci-Mater M 2008; 19(6): 2281-6.
103. Hashimoto Y, Kawashima M, Hatanaka R, Kusunoki M, Nishikawa H, Hontsu S, et al. Cytocompatibility of calcium phosphate coatings deposited by an ArF pulsed laser. J Mater Sci-Mater M 2008; 19(1): 327-33.
104. Muller L, Conforto E, Caillard D, Muller FA. Biomimetic apatite coatings -Carbonate substitution and preferred growth orientation. Biomol Eng 2007; 24(5): 462-6.
105. Choi JM, Kim HE, Lee IS. Ion-beam-assisted deposition (IBAD) of hydroxyapatite coating layer on Ti-based metal substrate. Biomaterials 2000; 21(5): 469-73.
106. Leeuwenburgh SC, Wolke JG, Siebers MC, Schoonman J, Jansen JA. In vitro and in vivo reactivity of porous, electrosprayed calcium phosphate coatings. Biomaterials 2006; 27(18): 3368-78.
107. de Jonge LT, Leeuwenburgh SC, Wolke JG, Jansen JA. Organic-inorganic surface modifications for titanium implant surfaces. Pharm Res 2008; 25(10): 2357-69.
108. Shepperd JAN, Apthorp H. A contemporary snapshot of the use of hydroxyapatite coating in orthopaedic surgery. J Bone Joint Surg Br 2005; 87B(8): 1046-9.
109. Rey C, Combes C, Drouet C, Glimcher MJ. Bone mineral: update on chemical composition and structure. Osteoporosis Int 2009; 20(6): 1013-21.
110. Grynpas MD, Bonar LC, Glimcher MJ. X-ray diffraction radial distribution function studies on bone mineral and synthetic calcium phosphates. J Mater Sci 1984; 19(3): 723-36.
111. Eichert D. Ph.D. Thesis, INPT France; 2001.
112. Legros R, Balmain N, Bonel G. Age-related changes in mineral of rat and bovine cortical bone. Calcif Tissue Int 1987; 41(3): 137-44.
113. Paschalis EP, DiCarlo E, Betts F, Sherman P, Mendelsohn R, Boskey AL. FTIR microspectroscopic analysis of human osteonal bone. Calcified Tissue Int 1996; 59(6): 480-7.
114. Rey C, Collins B, Goehl T, Dickson IR, Glimcher MJ. The Carbonate Environment in Bone-Mineral -a Resolution-Enhanced Fourier-Transform Infrared-Spectroscopy Study. Calcified Tissue Int 1989; 45(3): 157-64.
115. Rey C, Shimizu M, Collins B, Glimcher MJ. Resolution-enhanced Fourier transform infrared spectroscopy study of the environment of phosphate ions in the early deposits of a solid phase of calcium-phosphate in bone and enamel, and their evolution with age. I: Investigations in the upsilon 4 PO4 domain. Calcif Tissue Int 1990; 46(6): 384-94.
116. Combes C, Rey C, Mounic S. Identification and evaluation of HPO4 ions in biomimetic poorly crystalline apatite and bone mineral. Key Eng Mater 2001; 192-195: 143-6.
117. Drouet C, Carayon MT, Combes C, Rey C. Surface enrichment of biomimetic apatites with biologically-active ions Mg2+ and Sr2+: A preamble to the activation of bone repair materials. Mat Sci Eng C-Bio S 2008; 28(8): 1544-50.
118. Eichert C, Drouet C, Sfihi H, Rey C, Combes C. Nanocrystalline apatite-based biomaterials: synthesis, processing and characterization. In: Kendall JB, editor. Biomaterials Research Advances Nova Science Publishers; 2007. p. 93-143.
119. Hina A. Ph.D. Thesis, INPT France; 1996.
120. Sfihi H, Rey C. 1-D and 2-D double heteronuclear magnetic resonance study of the local structure of type B carbonate fluoroapatite. In: Fraissard F, Lapina B, editors. Magnetic Resonance in Colloid and Interface Science: Kluwer Academic Publishers.; 2002. p. 409-18.
121. Rey C, Combes C, Drouet C, Sfihi H, Barroug A. Physico-chemical properties of nanocrystalline apatites: Implications for biominerals and biomaterials. Mat Sci Eng C-Bio S 2007; 27(2): 198-205.
122. Cho G, Wu Y, Ackerman JL. Detection of hydroxyl ions in bone mineral by solid-state NMR spectroscopy. Science 2003; 300(5622): 1123-7.
123. Cho G, Yesinowski JP. H-1 and F-19 multiple-quantum NMR dynamics in quasi-onedimensional spin clusters in apatites. J Phys Chem-Us 1996; 100(39): 15716-25.
124. Miquel JL, Facchini L, Legrand AP, Rey C, Lemaitre J. Solid-State Nmr to Study Calcium-Phosphate Ceramics. Colloids Surf 1990; 45: 427-33.
125. Aue WP, Roufosse AH, Glimcher MJ, Griffin RG. Solid-state phosphorus-31 nuclear magnetic resonance studies of synthetic solid phases of calcium phosphate: potential models of bone mineral. Biochemistry 1984; 23(25): 6110-4.
126. Pourpoint F, Gervais C, Bonhomme-Coury L, Azaïs T, Coelho C, Mauri F, et al. Calcium phosphates and hydroxyapatite: solid-state NMR experiments and first-principles calculations. Appl Magn Reson 2007; 32(4): 435-57.
127. Roufosse AH, Aue WP, Roberts JE, Glimcher MJ, Griffin RG. Investigation of the mineral phases of bone by solid-state phosphorus-31 magic angle sample spinning nuclear magnetic resonance. Biochemistry 1984; 23(25): 6115-20.
128. Roberts JE, Bonar LC, Griffin RG, Glimcher MJ. Characterization of very young mineral phases of bone by solid state 31phosphorus magic angle sample spinning nuclear magnetic resonance and X-ray diffraction. Calcif Tissue Int 1992; 50(1): 42-8.
129. Wu Y, Glimcher MJ, Rey C, Ackerman JL. A unique protonated phosphate group in bone mineral not present in synthetic calcium phosphates. Identification by phosphorus-31 solid state NMR spectroscopy. J Mol Biol 1994; 244(4): 423-35.
130. Jarlbring M, Sandstrom DE, Antzutkin ON, Forsling W. Characterization of active phosphorus surface sites at synthetic carbonate-free fluorapatite using single-pulse H-1, P-31, and T-31 CP MAS NMR. Langmuir 2006; 22(10): 4787-92.
131. Kaflak A, Kolodziejski W. Kinetics H-1 -> P-31 NMR cross-polarization in bone apatite and its mineral standards. Magn Reson Chem 2008; 46(4): 335-41.
132. Sakhno Y, Bertinetti L, Iafisco M, Tampieri A, Roveri N, Martra G. Surface Hydration and Cationic Sites of Nanohydroxyapatites with Amorphous or Crystalline Surfaces: A Comparative Study. J Phys Chem C 2010; 114(39): 16640-8.
133. Drouet C, Bosc F, Banu M, Largeot C, Combes C, Dechambre G, et al. Nanocrystalline apatites: From powders to biomaterials. Powder Technol 2009; 190(1-2): 118-22.
134. Cazalbou S, Eichert D, Ranz X, Drouet C, Combes C, Harmand MF, et al. Ion exchanges in apatites for biomedical application. J Mater Sci-Mater M 2005; 16(5): 405-9.
135. Cazalbou S, Combes C, Eichert D, Rey C, Glimcher MJ. Poorly crystalline apatites: evolution and maturation in vitro and in vivo. J Bone Miner Metab 2004; 22(4): 310-7.
136. Cazalbou S, Combes C, Eichert D, Rey C. Adaptative physico-chemistry of bio-related calcium phosphates. J Mater Chem 2004; 14(14): 2148-53.
137. Cazalbou S. Ph.D. Thesis, INPT France; 2000.
138. Midy V, Rey C, Bres E, Dard M. Basic fibroblast growth factor adsorption and release properties of calcium phosphate. J Biomed Mater Res1998; 41(3): 405-11.
139. Quizat S, Barroug A, Legrouri A, Rey C. Adsorption of bovine serum albumin on poorly crystalline apatite: Influence of maturation. Mater Res Bull 1999; 34(14-15): 2279-89.
140. Rey C, Kim HM, Glimcher MJ. Maturation of poorly crystalline synthetic and biological apatites. In: Brown PW, Constantz B, editors. Hydroxyapatite and Related Materials: Boca Raton, CRC Press; 1994. p. 181-7.
141. Bertinetti L, Drouet C, Combes C, Rey C, Tampieri A, Coluccia S, et al. Surface Characteristics of Nanocrystalline Apatites: Effect of Mg Surface Enrichment on Morphology, Surface Hydration Species, and Cationic Environments. Langmuir 2009; 25(10): 5647-54.
142. Bracci B, Torricelli P, Panzavolta S, Boanini E, Giardino R, Bigi A. Effect of Mg2+, Sr2+, and Mn2+ on the chemico-physical and in vitro biological properties of calcium phosphate biomimetic coatings. J Inorg Biochem 2009; 103(12): 1666-74.
143. Habibovic P, Sees TM, van den Doel MA, van Blitterswijk CA, de Groot K. Osteoinduction by biomaterials--physicochemical and structural influences. J Biomed Mater Res A 2006; 77(4): 747-62.
144. Autefage H, Briand-Mesange F, Cazalbou S, Drouet C, Fourmy D, Goncalves S, et al. Adsorption and Release of BMP-2 on Nanocrystalline Apatite-Coated and Uncoated Hydroxyapatite/beta-Tricalcium Phosphate Porous Ceramics. J Biomed Mater Res B 2009; 91B(2): 706-15.
145. Grossin D, Rollin-Martinet S, Estournes C, Rossignol F, Champion E, Combes C, et al. Biomimetic apatite sintered at very low temperature by spark plasma sintering: Physicochemistry and microstructure aspects. Acta Biomater 2010; 6(2): 577-85.
146. Banu M. Ph.D. Thesis, INPT France; 2005.
147. Drouet C, Largeot C, Raimbeaux G, Estournes C, Dechambre G, Combes C, et al. Bioceramics: spark plasma sintering (SPS) of calcium phosphates. Adv Sci Technol 2006; 49: 45-50.
148. Uddin MH, Matsumoto T, Ishihara S, Nakahira A, Okazaki M, Sohmura T. Apatite containing aspartic acid for selective protein loading. J Dent Res 2010; 89(5): 488-92.
149. Mondejar SP, Kovtun A, Epple M. Lanthanide-doped calcium phosphate nanoparticles with high internal crystallinity and with a shell of DNA as fluorescent probes in cell experiments. J Mater Chem 2007; 17(39): 4153-9.
150. Al-Kattan A, Dufour P, Dexpert-Ghys J, Drouet C. Preparation and Physicochemical Characteristics of Luminescent Apatite-Based Colloids. J Phys Chem C 2010; 114(7): 2918-24.
151. Bouladjine A, Al-Kattan A, Dufour P, Drouet C. New Advances in Nanocrystalline Apatite Colloids Intended for Cellular Drug Delivery. Langmuir 2009; 25(20): 12256-65.
152. Chane-Ching JY, Lebugle A, Rousselot I, Pourpoint A, Pelle F. Colloidal synthesis and characterization of monocrystalline apatite nanophosphors. J Mater Chem 2007; 17(28): 2904-13.
153. Saha SK, Banerjee A, Banerjee S, Bose S. Synthesis of nanocrystalline hydroxyapatite using surfactant template systems: Role of templates in controlling morphology. Mat Sci Eng CMater 2009; 29(7): 2294-301.
154. Chander S, Fuerstenau DW. Solubility and interfacial properties of hydroxyapatite: a review. In: Misra DN, editor. Adsorption on, and surface chemistry of hydroxyapatite: Plenum Press: New York; 1984.p. 29-49.
155. Tung MS, Skrtic D. Interfacial properties of hydroxyapatite, fluorapatite and octacalcium phosphate. In: Chow LC, Eanes ED, editors. Octacalcium phosphate, Monographs in oral science: Karger; 2001. p. 112-29.
156. Saleeb FZ, De Bruyn PL. Surface properties of alkaline earth apatites. J Electroanal Chem 1972; 37(1): 99-118.
157. Mangood A, Malkaj P, Dalas E. Hydroxyapatite crystallization in the presence of acetaminophen. J Cryst Growth 2006; 290(2): 565-70.
158. Burke EM, Nancollas GH. Relation of lattice ion solution composition to octacalcium phosphate dissolution kinetics. Colloid Surface A 1999; 150(1-3): 151-60.
159. Nancollas GH, Wu WJ. Biomineralization mechanisms: a kinetics and interfacial energy approach. J Cryst Growth 2000; 211(1-4): 137-42.
160. Wu WJ, Nancollas GH. Determination of interfacial tension from crystallization and dissolution data: a comparison with other methods. Adv Colloid Interfac 1999; 79(2-3): 229-79.
161. Pietronave S, Iafisco M, Locarno D, Rimondini L, Prat M. Functionalized nanomaterials for diagnosis and therapy of cancer. J Appl Biomater Biom 2009; 7(2): 77-89.
162. Kasemo B, Gold J. Implant surfaces and interface processes. Adv Dent Res. 1999; 13: 8-20.
163. El-Ghannam A, Ducheyne P, Shapiro IM. Effect of serum proteins on osteoblast adhesion to surface-modified bioactive glass and hydroxyapatite. J Orthopaed Res 1999; 17(3): 340-5.
164. Kandori K, Masunari A, Ishikawa T. Study on adsorption mechanism of proteins onto synthetic calcium hydroxyapatites through ionic concentration measurements. Calcified Tissue Int 2005; 76(3): 194-206.
165. Makrodimitris K, Masica DL, Kim ET, Gray JJ. Structure prediction of protein-solid surface interactions reveals a molecular recognition motif of statherin for hydroxyapatite. J Am Chem Soc 2007; 129(44): 13713-22.
166. Baeza A, Izquierdo-Barba I, Vallet-Regi M. Biotinylation of silicon-doped hydroxyapatite: A new approach to protein fixation for bone tissue regeneration. Acta Biomater 2010; 6(3): 743-9.
167. Iafisco M, Marchetti M, Morales JG, Hernandez-Hernandez MA, Ruiz JMG, Roveri N. Silica Gel Template for Calcium Phosphates Crystallization. Cryst Growth Des 2009; 9(11): 4912-21.
168. Iafisco M, Morales JG, Hernandez-Hernandez MA, Garcia-Ruiz JM, Roveri N. Biomimetic Carbonate-Hydroxyapatite Nanocrystals Prepared by Vapor Diffusion. Adv Eng Mater 2010; 12(7): B218-B23.
169. Koutsopoulos S, Dalas E. The crystallization of hydroxyapatite in the presence of lysine. J Colloid Interf Sci 2000; 231(2): 207-12.
170. Koutsopoulos S, Dalas E. Hydroxyapatite crystallization in the presence of serine, tyrosine and hydroxyproline amino acids with polar side groups. J Cryst Growth 2000; 216(1-4): 443-9.
171. Koutsopoulos S, Dalas E. Hydroxyapatite crystallization in the presence of amino acids with uncharged polar side groups: Glycine, cysteine, cystine, and glutamine. Langmuir 2001; 17(4): 1074-9.
172. Gonzalez-McQuire R, Chane-Ching JY, Vignaud E, Lebugle A, Mann S. Synthesis and characterization of amino acid-functionalized hydroxyapatite nanorods. J Mater Chem 2004; 14(14): 2277-81.
173. Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A. Nanocomposites of hydroxyapatite with aspartic acid and glutamic acid and their interaction with osteoblast-like cells. Biomaterials 2006; 27(25): 4428-33.
174. Rosseeva EV, Golovanova OA, Frank-Kamenetskaya OV. The influence of amino acids on the formation of nanocrystalline hydroxyapatite. Glass Phys Chem 2007; 33(3): 283-6.
175. Jack KS, Vizcarra TG, Trau M. Characterization and surface properties of amino-acidmodified, carbonate-containing hydroxyapatite particles. Langmuir 2007; 23(24): 12233-42.
176. Palazzo B, Walsh D, Iafisco M, Foresti E, Bertinetti L, Martra G, et al. Amino acid synergetic effect on structure, morphology and surface properties of biomimetic apatite nanocrystals. Acta Biomater 2009; 5(4): 1241-52.
177. Boix T, Gomez-Morales J, Torrent-Burgues J, Monfort A, Pulgdomenech P, Rodriguez-Clemente R. Adsorption of recombinant human bone morphogenetic protein rhBMP-2m onto hydroxyapatite. J Inorg Biochem 2005; 99(5): 1043-50.
178. Iafisco M, Sabatino P, Lesci IG, Prat M, Rimondini L, Roveri N. Conformational modifications of serum albumins adsorbed on different kinds of biomimetic hydroxyapatite nanocrystals. Colloids Surf B. 2010; 81(1): 274-84.
179. Iafisco M, Palazzo B, Falini G, Foggia MD, Bonora S, Nicolis S, et al. Adsorption and conformational change of myoglobin on biomimetic hydroxyapatite nanocrystals functionalized with alendronate. Langmuir 2008; 24(9): 4924-30.
180. El Shafei GMS, Moussa NA. Adsorption of some essential amino acids on hydroxyapatite. J Colloid Interf Sci 2001; 238(1): 160-6.
181. Wu LM, Forsling W, Schindler PW. Surface Complexation of Calcium Minerals in Aqueous-Solution.1. Surface Protonation at Fluorapatite Water Interfaces. J Colloid Interf Sci 1991; 147(1): 178-85.
182. Yin G, Liu Z, Zhan J, Ding FX, Yuan NJ. Impacts of the surface charge property on protein adsorption on hydroxyapatite. Chem Eng J 2002; 87(2): 181-6.
183. Kawasaki K, Kambara M, Matsumura H, Norde W. A comparison of the adsorption of saliva proteins and some typical proteins onto the surface of hydroxyapatite. Colloids Surf B 2003; 32(4): 321-34.
184. Smith DA, Connell SD, Robinson C, Kirkham J. Chemical force microscopy: applications in surface characterisation of natural hydroxyapatite. Anal Chim Acta 2003; 479(1): 39-57.
185. Stayton PS, Drobny GP, Shaw WJ, Long JR, Gilbert M. Molecular recognition at the proteinhydroxyapatite interface. Crit Rev Oral Biol M 2003; 14(5): 370-6.
186. Schwartz SS, Hay DI, Schluckebier SK. Inhibition of calcium phosphate precipitation by human salivary statherin: structure-activity relationships. Calcif Tissue Int 1992; 50(6): 511-7.
187. Hay DI, Smith DJ, Schluckebier SK, Moreno EC. Relationship between concentration of human salivary statherin and inhibition of calcium phosphate precipitation in stimulated human parotid saliva. J Dent Res 1984; 63(6): 857-63.
188. Douglas WH, Reeh ES, Ramasubbu N, Raj PA, Bhandary KK, Levine MJ. Statherin -a Major Boundary Lubricant of Human Saliva. Biochem Bioph Res Co 1991; 180(1): 91-7.
189. Moreno EC, Kresak M, Hay DI. Adsorption of two human parotid salivary macromolecules on hydroxy-, fluorhydroxy-and fluorapatites. Arch Oral Biol 1978; 23(7): 525-33.
190. Raj PA, Johnsson M, Levine MJ, Nancollas GH. Salivary Statherin -Dependence on Sequence, Charge, Hydrogen-Bonding Potency, and Helical Conformation for Adsorption to Hydroxyapatite and Inhibition of Mineralization. J Biol Chem 1992; 267(9): 5968-76.
191. Gibson JM, Raghunathan V, Popham JM, Stayton PS, Drobny GP. A REDOR NMR study of a phosphorylated statherin fragment bound to hydroxyapatite crystals. J Am Chem Soc 2005; 127(26): 9350-1.
192. Raghunathan V, Gibson JM, Goobes G, Popham JM, Louie EA, Stayton PS, et al. Homonuclear and heteronuclear NMR studies of a statherin fragment bound to hydroxyapatite crystals. J Phys Chem B 2006; 110(18): 9324-32.
193. Gibson JM, Popham JM, Raghunathan V, Stayton PS, Drobny GP. A solid-state NMR study of the dynamics and interactions of phenylalanine rings in a statherin fragment bound to hydroxyapatite crystals. J Am Chem Soc 2006; 128(16): 5364-70.
194. Goobes G, Goobes R, Shaw WJ, Gibson JM, Long JR, Raghunathan V, et al. The structure, dynamics, and energetics of protein adsorption-lessons learned from adsorption of statherin to hydroxyapatite. Magn Reson Chem 2008; 45(S1): S32-S47.
195. Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS. Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Bioph Res Co 2001; 280(2): 460-5.
196. Errassif F, Menbaoui A, Autefage H, Benaziz L, Ouizat S, Santran V, et al. Adsorption on Apatitic Calcium Phosphates: Applications to Drug Delivery In: Narayan R, Singh M, McKittrick J, editors. Advances in Bioceramics and Biotechnologies: Wiley-VCH Verlag GmbH & Co. KGaA; 2010. p. 159-174.
197. Aoba T, Moreno EC. Adsorption of Phosphoserine onto Hydroxyapatite and Its Inhibitory Activity on Crystal-Growth. J Colloid Interf Sci 1985; 106(1): 110-21.
198. Lopez-Macipe A, Gomez-Morales J, Rodriguez-Clemente R. The role of pH in the adsorption of citrate ions on hydroxyapatite. J Colloid Interf Sci 1998; 200(1): 114-20.
199. Rodan GA, Fleisch HA. Bisphosphonates: Mechanisms of action. J Clin Invest 1996; 97(12): 2692-6.
200. Russell RGG, Rogers MJ. Bisphosphonates: From the laboratory to the clinic and back again. Bone 1999; 25(1): 97-106.
201. Josse S, Faucheux C, Soueldan A, Grimandi G, Massiot D, Alonso B, et al. Novel biomaterials for bisphosphonate delivery. Biomaterials 2005; 26(14): 2073-80.
202. Roussiere H, Fayon F, Alonso B, Rouillon T, Schnitzler V, Verron E, et al. Reaction of zoledronate with beta-tricalcium phosphate for the design of potential drug device combined systems. Chem Mater 2008; 20(1): 182-91.
203. Stigter M, Bezemer J, de Groot K, Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 2004; 99(1): 127-37.
204. Misra DN. Interaction of some alkali metal citrates with hydroxyapatite -Ion-exchange adsorption and role of charge balance. Colloid Surface A 1998; 141(2): 173-9.
205. Barroug A, Fastrez J, Lemaitre J, Rouxhet P. Adsorption of succinylated lysozyme on hydroxyapatite. J Colloid Interf Sci 1997; 189(1): 37-42.
206. Barroug A, Lernoux E, Lemaitre J, Rouxhet PG. Adsorption of catalase on hydroxyapatite. J Colloid Interf Sci 1998; 208(1): 147-52.
207. Dong XL, Wang Q, Wu T, Pan HH. Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys J 2007; 93(3): 750-9.
208. Barroug A, Kuhn LT, Gerstenfeld LC, Glimcher MJ. Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release. J Orthopaed Res 2004; 22(4): 703-8.
209. Gautier H, Daculsi G, Merle C. Association of vancomycin and calcium phosphate by dynamic compaction: in vitro characterization and microbiological activity. Biomaterials 2001; 22(18): 2481-7.
210. Gautier H, Merle C, Auget JL, Daculsi G. Isostatic compression, a new process for incorporating vancomycin into biphasic calcium phosphate: comparison with a classical method. Biomaterials 2000; 21(3): 243-9.
211. Alam MI, Asahina I, Ohmamiuda K, Takahashi K, Yokota S, Enomoto S. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. Biomaterials 2001; 22(12): 1643-51.
212. Liu YL, Enggist L, Kuffer AF, Buser D, Hunziker EB. The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. Biomaterials 2007; 28(16): 2677-86.
213. Peter B, Pioletti DP, Laib S, Bujoli B, Pilet P, Janvier P, et al. Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone 2005; 36(1): 52-60.
214. Lebugle A, Rodrigues A, Bonnevialle P, Voigt JJ, Canal P, Rodriguez F. Study of implantable calcium phosphate systems for the slow release of methotrexate. Biomaterials 2002; 23(16): 3517-22.
215. Midy V, Hollande E, Rey C, Dard M, Plouet J. Adsorption of vascular endothelial growth factor to two different apatitic materials and its release. J Mater Sci-Mater M 2001; 12(4): 293-8.
216. Yoshinari M, Oda Y, Ueki H, Yokose S. Immobilization of bisphosphonates on surface modified titanium. Biomaterials 2001; 22(7): 709-15.
217. McLeod K, Kumar S, Smart RSC, Dutta N, Voelcker NH, Anderson GI, et al. XPS and bioactivity study of the bisphosphonate pamidronate adsorbed onto plasma sprayed hydroxyapatite coatings. Appl Surf Sci 2006; 253(5): 2644-51.
218. Errassifi F, Sarda S, Barroug A, Lebugle A, Legrouri A, Sfihi HA, et al. editors. Adsorption of a bisphosphonate onto apatitic calcium phosphates: Role of surface characteristics. Third Conference on the Valorization of Phosphates and Phosphorous compounds (COVAPHOS III) 2009; Marrakech.
219. Iafisco M, Palazzo B, Marchetti M, Margiotta N, Ostuni R, Natile G, et al. Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals. J Mater Chem 2009; 19(44): 8385-92.
220. Palazzo B, Iafisco M, Laforgia M, Margiotta N, Natile G, Bianchi CL, et al. Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Adv Funct Mater 2007; 17(13): 2180-8.
221. Neves M, Gano L, Pereira N, Costa MC, Costa MR, Chandia M, et al. Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies. Nucl Med Biol 2002; 29(3): 329-38.
222. Coxon FP, Thompson K, Rogers MJ. Recent advances in understanding the mechanism of action of bisphosphonates. Curr Opin Pharmacol 2006; 6(3): 307-12.
223. Rogers MJ, Watts DJ, Russell RGG. Overview of bisphosphonates. Cancer 1997; 80(8): 1652-60.
224. Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, et al. Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite. Bone 2006; 38(5): 617-27.
225. Russell RGG. Determinants of structure-function relationships among bisphosphonates. Bone 2007; 40(5): S21-S5.
226. Lalla S, Hothorn LA, Haag N, Bader R, Bauss F. Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats. Osteoporosis Int 1998; 8(2): 97-103.
227. Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, et al. The Effects of 2-Year Treatment with the Aminobisphosphonate Alendronate on Bone Metabolism, Bone Histomorphometry, and Bone Strength in Ovariectomized Nonhuman-Primates. J Clin Invest 1993; 92(6): 2577-86.
228. Monkkonen J, Simila J, Rogers MJ. Effects of tiludronate and ibandronate on the secretion of proinflammatory cytokines and nitric oxide from macrophages in vitro. Life Sci 1998; 62(8): Pl95-Pl102.
229. Elliott SN, McKnight W, Davies NM, MacNaughton WK, Wallace JL. Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci 1997; 62(1): 77-91.
230. Kos M, Kuebler JF, Luczak K, Engelke W. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk. J Craniomaxillofac Surg 2010; 38(4): 255-9.
231. Kos M, Luczak K. Bisphosphonates promote jaw osteonecrosis through facilitating bacterial colonisation. Bioscience Hypotheses 2009; 2(1): 34-6.
232. Hoffman A, Stepensky D, Ezra A, Van Gelder JM, Golomb G. Mode of administrationdependent pharmacokinetics of bisphosphonates and bioavailability determination. Int J Pharm 2001; 220(1-2): 1-11.
233. Marie PJ, Ammann P, Boivin G, Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcified Tissue Int 2001; 69(3): 121-9.
234. Ringe JD. Strontium ranelate: an effective solution for diverse fracture risks. Osteoporos Int 2010; 21 Suppl 2: S431-6.
235. Chen QZ, Wong CT, Lu WW, Cheung KM, Leong JC, Luk KD. Strengthening mechanisms of bone bonding to crystalline hydroxyapatite in vivo. Biomaterials 2004; 25(18): 4243-54.
236. Ni GX, Lu WW, Xu B, Chiu KY, Yang C, Li ZY, et al. Interfacial behaviour of strontiumcontaining hydroxyapatite cement with cancellous and cortical bone. Biomaterials 2006; 27(29): 5127-33.
237. Hayashi K, Uenoyama K, Matsuguchi N, Nakagawa S, Sugioka Y. The affinity of bone to hydroxyapatite and alumina in experimentally induced osteoporosis. J Arthroplasty 1989; 4(3): 257-62.
238. Ni GX, Lu WW, Chiu KY, Li ZY, Fong DY, Luk KD. Strontium-containing hydroxyapatite (Sr-HA) bioactive cement for primary hip replacement: an in vivo study. J Biomed Mater Res B Appl Biomater 2006; 77(2): 409-15.
239. Chen D, Fu Y, Gu G, Qian Y, Gu Y. Preparation and solubility of the solid solution of strontium substituted hydroxyapatite. Chin J Biomed Eng. 2001; 20(3): 278-80.
240. Wong KL, Wong CT, Liu WC, Pan HB, Fong MK, Lam WM, et al. Mechanical properties and in vitro response of strontium-containing hydroxyapatite/polyetheretherketone composites. Biomaterials 2009; 30(23-24): 3810-7.
241. Gough JE, Jones JR, Hench LL. Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 2004; 25(11): 2039-46.
242. Wong CT, Chen QZ, Lu WW, Leong JCY, Chan WK, Cheung KMC, et al. Ultrastructural study of mineralization of a strontium-containing hydroxyapatite (Sr-HA) cement in vivo. J Biomed Mater Res A 2004; 70A(3): 428-35.
243. Romieu G, Garric X, Munier S, Vert M, Boudeville P. Calcium-strontium mixed phosphate as novel injectable and radio-opaque hydraulic cement. Acta Biomater 2010; 6(8): 3208-15.
244. Panzavolta S, Torricelli P, Sturba L, Bracci B, Giardino R, Bigi A. Setting properties and in vitro bioactivity of strontium-enriched gelatin-calcium phosphate bone cements. J Biomed Mater Res A 2008; 84(4): 965-72.
245. Xue WC, Hosick HL, Bandyopadhyay A, Bose S, Ding CX, Luk KDK, et al. Preparation and cell-materials interactions of plasma sprayed strontium-containing hydroxyapatite coating. Surf Coat Tech 2007; 201(8): 4685-93.
246. Guo DG, Xu KW, Han Y. The influence of Sr doses on the in vitro biocompatibility and in vivo degradability of single-phase Sr-incorporated HAP cement. J Biomed Mater Res A 2008; 86A(4): 947-58.
247. Landi E, Sprio S, Sandri M, Celotti G, Tampieri A. Development of Sr and CO3 co-substituted hydroxyapatites for biomedical applications. Acta Biomater 2008; 4(3): 656-63.